Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Focused review: ropivacaine versus bupivacaine for epidural labor analgesia Beilin Y; Halpern SAnesth Analg 2010[Aug]; 111 (2): 482-7Neuraxial analgesia is frequently administered to women in labor. For many years, bupivacaine has been used because of its long duration of action, lack of excessive motor block, and minimal fetal and neonatal effects. However, bupivacaine is one of the most cardiotoxic local anesthetics in current use and motor block is still a problem. Many local anesthetics such as bupivacaine exist in 2 forms, levorotatory and dextrorotatory. Ropivacaine, an amide local anesthetic produced in the pure levorotatory form addresses some of the concerns related to bupivacaine. In this article, we present the literature comparing ropivacaine and bupivacaine to determine whether there is an advantage to using one of these local anesthetics for labor analgesia. We found that there is no advantage to the routine use of ropivacaine for labor analgesia.|Amides/*administration & dosage/adverse effects/economics[MESH]|Analgesia, Epidural/adverse effects/economics/*methods[MESH]|Analgesia, Obstetrical/adverse effects/economics/*methods[MESH]|Anesthetics, Local/*administration & dosage/adverse effects/economics[MESH]|Animals[MESH]|Bupivacaine/*administration & dosage/adverse effects/economics[MESH]|Consumer Product Safety[MESH]|Cost-Benefit Analysis[MESH]|Dose-Response Relationship, Drug[MESH]|Drug Costs[MESH]|Evidence-Based Medicine[MESH]|Female[MESH]|Humans[MESH]|Labor Pain/*drug therapy[MESH]|Motor Activity/drug effects[MESH]|Pregnancy[MESH]|Risk Assessment[MESH]|Ropivacaine[MESH]|Treatment Outcome[MESH] |